CDX2 can be expressed in neuroendocrine carcinomas of pancreas and non-GI tract high-grade neuroendocrine carcinomas, such as those of the bladder and lung [44,45,51]. This evidence concerns the gene CDX2 and pancreatic endocrine carcinoma.